_id

690db037ccc777a4e85d0b64

Ticker

AQST

Name

Aquestive Therapeutics Inc

Exchange

NASDAQ

Address

30 Technology Drive, Warren, NJ, United States, 07059

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.aquestive.com

Description

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Last Close

6.21

Volume

3331167

Current Price

5.91

Change

-4.830917874396133

Last Updated

2025-11-28T12:20:15.540Z

Image

data:image/webp;base64,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

Ipo Date

2018-07-25T00:00:00.000Z

Market Cap

758859328

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.982

Sentiment Sources

1

Rating

4.5556

Target Price

10.3

Strong Buy

5

Buy

4

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

12807000

Cost Of Revenue

4506000

Gross Profit

8301000

Operating Expenses

19780000

Operating Income

-11479000

Interest Expense

4273000

Pretax Income

-15446000

Net Income

-15446000

Eps

-0.13967615731159697

Dividends Per Share

-

Shares Outstanding

122003113

Income Tax Expense

-

EBITDA

-11034000

Operating Margin

-89.6306707269462

Total Other Income Expense Net

-3967000

Cash

129062999

Short Term Investments

-

Receivables

11801000

Inventories

7884000

Total Current Assets

151673000

Property Plant Equipment

8687000

Total Assets

163559000

Payables

10865000

Short Term Debt

8489000

Long Term Debt

29940000

Total Liabilities

167668000

Equity

-4109000

Depreciation

139000

Change In Working Capital

-2878000

Cash From Operations

-12649000

Capital Expenditures

235000

Cash From Investing

-235000

Cash From Financing

81411000

Net Change In Cash

68527000

PE

-

PB

-159.05418170114382

ROE

375.9065466050134

ROA

-9.443686987570235

FCF

-12884000

Fcf Percent

-1.0060123370032015

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

1

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.8

Garp Investing Score

4

Growth Investing Score

4

Momentum Investing Score

2.5

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

12807000

Quarters > 0 > income Statement > cost Of Revenue

4506000

Quarters > 0 > income Statement > gross Profit

8301000

Quarters > 0 > income Statement > operating Expenses

19780000

Quarters > 0 > income Statement > operating Income

-11479000

Quarters > 0 > income Statement > interest Expense

4273000

Quarters > 0 > income Statement > pretax Income

-15446000

Quarters > 0 > income Statement > net Income

-15446000

Quarters > 0 > income Statement > eps

-0.13967615731159697

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

110584371

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-11034000

Quarters > 0 > income Statement > operating Margin

-89.6306707269462

Quarters > 0 > income Statement > total Other Income Expense Net

-3967000

Quarters > 0 > balance Sheet > cash

129062999

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

11801000

Quarters > 0 > balance Sheet > inventories

7884000

Quarters > 0 > balance Sheet > total Current Assets

151673000

Quarters > 0 > balance Sheet > property Plant Equipment

8687000

Quarters > 0 > balance Sheet > total Assets

163559000

Quarters > 0 > balance Sheet > payables

10865000

Quarters > 0 > balance Sheet > short Term Debt

8489000

Quarters > 0 > balance Sheet > long Term Debt

29940000

Quarters > 0 > balance Sheet > total Liabilities

167668000

Quarters > 0 > balance Sheet > equity

-4109000

Quarters > 0 > cash Flow > net Income

-15446000

Quarters > 0 > cash Flow > depreciation

139000

Quarters > 0 > cash Flow > change In Working Capital

-2878000

Quarters > 0 > cash Flow > cash From Operations

-12649000

Quarters > 0 > cash Flow > capital Expenditures

235000

Quarters > 0 > cash Flow > cash From Investing

-235000

Quarters > 0 > cash Flow > cash From Financing

81411000

Quarters > 0 > cash Flow > net Change In Cash

68527000

Quarters > 0 > ratios > PE

-0.13967615731159697

Quarters > 0 > ratios > PB

-159.05418170114382

Quarters > 0 > ratios > ROE

375.9065466050134

Quarters > 0 > ratios > ROA

-9.443686987570235

Quarters > 0 > ratios > FCF

-12884000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-1.0060123370032015

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

10003000

Quarters > 1 > income Statement > cost Of Revenue

4561000

Quarters > 1 > income Statement > gross Profit

5442000

Quarters > 1 > income Statement > operating Expenses

16810000

Quarters > 1 > income Statement > operating Income

-11368000

Quarters > 1 > income Statement > interest Expense

4276000

Quarters > 1 > income Statement > pretax Income

-13548000

Quarters > 1 > income Statement > net Income

-13548000

Quarters > 1 > income Statement > eps

-0.13639836885350698

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

99326701

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-9132000

Quarters > 1 > income Statement > operating Margin

-113.64590622813155

Quarters > 1 > income Statement > total Other Income Expense Net

-2180000

Quarters > 1 > balance Sheet > cash

60536000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

11864000

Quarters > 1 > balance Sheet > inventories

8125000

Quarters > 1 > balance Sheet > total Current Assets

81721000

Quarters > 1 > balance Sheet > property Plant Equipment

8769000

Quarters > 1 > balance Sheet > total Assets

93698000

Quarters > 1 > balance Sheet > payables

11951000

Quarters > 1 > balance Sheet > short Term Debt

3747000

Quarters > 1 > balance Sheet > long Term Debt

31843000

Quarters > 1 > balance Sheet > total Liabilities

166288000

Quarters > 1 > balance Sheet > equity

-72590000

Quarters > 1 > cash Flow > net Income

-13548000

Quarters > 1 > cash Flow > depreciation

140000

Quarters > 1 > cash Flow > change In Working Capital

919000

Quarters > 1 > cash Flow > cash From Operations

-7914000

Quarters > 1 > cash Flow > capital Expenditures

107000

Quarters > 1 > cash Flow > cash From Investing

-107000

Quarters > 1 > cash Flow > cash From Financing

-100000

Quarters > 1 > cash Flow > net Change In Cash

-8121000

Quarters > 1 > ratios > PE

-0.13639836885350698

Quarters > 1 > ratios > PB

-8.08679987477614

Quarters > 1 > ratios > ROE

18.663727786196446

Quarters > 1 > ratios > ROA

-14.459220047386284

Quarters > 1 > ratios > FCF

-8021000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.8018594421673498

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

8720000

Quarters > 2 > income Statement > cost Of Revenue

3652000

Quarters > 2 > income Statement > gross Profit

5068000

Quarters > 2 > income Statement > operating Expenses

24433000

Quarters > 2 > income Statement > operating Income

-19365000

Quarters > 2 > income Statement > interest Expense

4278000

Quarters > 2 > income Statement > pretax Income

-22930000

Quarters > 2 > income Statement > net Income

-22930000

Quarters > 2 > income Statement > eps

-0.24011211403208074

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

95497056

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-15763000

Quarters > 2 > income Statement > operating Margin

-222.0756880733945

Quarters > 2 > income Statement > total Other Income Expense Net

-3565000

Quarters > 2 > balance Sheet > cash

68657000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

10444000

Quarters > 2 > balance Sheet > inventories

7198000

Quarters > 2 > balance Sheet > total Current Assets

89169000

Quarters > 2 > balance Sheet > property Plant Equipment

8850000

Quarters > 2 > balance Sheet > total Assets

102234000

Quarters > 2 > balance Sheet > payables

12280000

Quarters > 2 > balance Sheet > short Term Debt

567000

Quarters > 2 > balance Sheet > long Term Debt

33746000

Quarters > 2 > balance Sheet > total Liabilities

163164000

Quarters > 2 > balance Sheet > equity

-60930000

Quarters > 2 > cash Flow > net Income

-22930000

Quarters > 2 > cash Flow > depreciation

139000

Quarters > 2 > cash Flow > change In Working Capital

-4992000

Quarters > 2 > cash Flow > cash From Operations

-23400000

Quarters > 2 > cash Flow > capital Expenditures

135000

Quarters > 2 > cash Flow > cash From Investing

-135000

Quarters > 2 > cash Flow > cash From Financing

20646000

Quarters > 2 > cash Flow > net Change In Cash

-2889000

Quarters > 2 > ratios > PE

-0.24011211403208074

Quarters > 2 > ratios > PB

-9.26288529394387

Quarters > 2 > ratios > ROE

37.63334974560972

Quarters > 2 > ratios > ROA

-22.42893753545787

Quarters > 2 > ratios > FCF

-23535000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-2.698967889908257

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

11867000

Quarters > 3 > income Statement > cost Of Revenue

4520000

Quarters > 3 > income Statement > gross Profit

7347000

Quarters > 3 > income Statement > operating Expenses

20926000

Quarters > 3 > income Statement > operating Income

-13579000

Quarters > 3 > income Statement > interest Expense

4224000

Quarters > 3 > income Statement > pretax Income

-17069000

Quarters > 3 > income Statement > net Income

-17055000

Quarters > 3 > income Statement > eps

-0.18700779490814012

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

91199407

Quarters > 3 > income Statement > income Tax Expense

-14000

Quarters > 3 > income Statement > EBITDA

-12698000

Quarters > 3 > income Statement > operating Margin

-114.42656105165585

Quarters > 3 > income Statement > total Other Income Expense Net

-3490000

Quarters > 3 > balance Sheet > cash

71546000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

7344000

Quarters > 3 > balance Sheet > inventories

6044000

Quarters > 3 > balance Sheet > total Current Assets

88220000

Quarters > 3 > balance Sheet > property Plant Equipment

8981000

Quarters > 3 > balance Sheet > total Assets

101424000

Quarters > 3 > balance Sheet > payables

10287000

Quarters > 3 > balance Sheet > short Term Debt

536000

Quarters > 3 > balance Sheet > long Term Debt

32500000

Quarters > 3 > balance Sheet > total Liabilities

161580000

Quarters > 3 > balance Sheet > equity

-60156000

Quarters > 3 > cash Flow > net Income

-17055000

Quarters > 3 > cash Flow > depreciation

147000

Quarters > 3 > cash Flow > change In Working Capital

5284000

Quarters > 3 > cash Flow > cash From Operations

-6489000

Quarters > 3 > cash Flow > capital Expenditures

15000

Quarters > 3 > cash Flow > cash From Investing

-15000

Quarters > 3 > cash Flow > cash From Financing

157000

Quarters > 3 > cash Flow > net Change In Cash

-6347000

Quarters > 3 > ratios > PE

-0.18700779490814012

Quarters > 3 > ratios > PB

-8.959845989926192

Quarters > 3 > ratios > ROE

28.351286654697788

Quarters > 3 > ratios > ROA

-16.815546616185518

Quarters > 3 > ratios > FCF

-6504000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.5480744922895424

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.13967615731159697

Valuation > metrics > PB

-159.05418170114382

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

375.9065466050134

Profitability > metrics > ROA

-10.183750568657572

Profitability > metrics > Net Margin

-1.206059186382447

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-2.6864029955534754

Risk > final Score

19

Risk > verdict

High

Liquidity > metrics > Current Ratio

7.836777927043506

Liquidity > metrics > Quick Ratio

7.429420274878578

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

37

Prev Profitabilities > 1

40

Prev Profitabilities > 2

40

Prev Risks > 0

19

Prev Risks > 1

12

Prev Risks > 2

17

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:24:55.263Z